Two-drug regimen for HIV

from Listen to The Lancet · host The Lancet

Jessamy Bagenal and Kimberly Smith discuss implications arising from the Gemini study, which shows how a two-drug combination is not inferior to a conventional three-drug regimen in the treatment of HIV.

Episode metadata supplied by the publisher feed · Published Nov 10, 2018

Embed this episode

Attribution link and audio player

NOW PLAYING

Two-drug regimen for HIV

0:00 11:09

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Listen to The Lancet?

This episode is 11 minutes long.

When was this Listen to The Lancet episode published?

This episode was published on November 10, 2018.

Can I download this Listen to The Lancet episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!